HighVista Strategies’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-66,526	Closed	-$468K	–	150
2023 Q2	$468K	Buy	+66,526	New	+$476K	0.21%	120
2022 Q4	–	Sell	-72,104	Closed	-$691K	–	114
2022 Q3	$691K	Buy	72,104 +27,142	+60%	+$313K	0.39%	70
2022 Q2	$496K	Sell	44,962 -9,439	-17%	-$124K	0.3%	76
2022 Q1	$906K	Sell	54,401 -12,238	-18%	-$189K	0.58%	44
2021 Q4	$1.27M	Buy	66,639 +10,363	+18%	+$228K	1.01%	31
2021 Q3	$1.39M	Buy	56,276 +23,818	+73%	+$561K	0.92%	23
2021 Q2	$845K	Buy	32,458 +14,295	+79%	+$372K	0.6%	35
2021 Q1	$575K	Sell	18,163 -2,260	-11%	-$93.7K	0.43%	63
2020 Q4	$948K	Buy	20,423 +3,599	+21%	+$143K	0.61%	31
2020 Q3	$554K	Buy	16,824 +1,343	+9%	+$41.2K	0.4%	38
2020 Q2	$425K	Buy	+15,481	New	+$509K	0.35%	45